ES2192832T3 - USE OF MACROLID COMPOUNDS TO TREAT GLAUCOMA. - Google Patents
USE OF MACROLID COMPOUNDS TO TREAT GLAUCOMA.Info
- Publication number
- ES2192832T3 ES2192832T3 ES99905206T ES99905206T ES2192832T3 ES 2192832 T3 ES2192832 T3 ES 2192832T3 ES 99905206 T ES99905206 T ES 99905206T ES 99905206 T ES99905206 T ES 99905206T ES 2192832 T3 ES2192832 T3 ES 2192832T3
- Authority
- ES
- Spain
- Prior art keywords
- compounds
- treat glaucoma
- macrolid
- macrolid compounds
- glaucoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Abstract
Macrolide compounds, such as the FK506 Substance and its related compounds, are provided for the prevention or treatment of eye diseases, particularly glaucoma. Composition containing such compounds is also disclosed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP1955A AUPP195598A0 (en) | 1998-02-23 | 1998-02-23 | New use |
AUPP2992A AUPP299298A0 (en) | 1998-04-16 | 1998-04-16 | New use |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2192832T3 true ES2192832T3 (en) | 2003-10-16 |
Family
ID=25645716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES99905206T Expired - Lifetime ES2192832T3 (en) | 1998-02-23 | 1999-02-17 | USE OF MACROLID COMPOUNDS TO TREAT GLAUCOMA. |
Country Status (9)
Country | Link |
---|---|
US (1) | US6384073B1 (en) |
EP (1) | EP1056454B1 (en) |
JP (1) | JP2002503692A (en) |
AT (1) | ATE238792T1 (en) |
DE (1) | DE69907418T2 (en) |
DK (1) | DK1056454T3 (en) |
ES (1) | ES2192832T3 (en) |
PT (1) | PT1056454E (en) |
WO (1) | WO1999042104A1 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7265150B1 (en) * | 1998-08-14 | 2007-09-04 | Gpi Nil Holdings Inc. | Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds for vision and memory disorders |
US6376517B1 (en) * | 1998-08-14 | 2002-04-23 | Gpi Nil Holdings, Inc. | Pipecolic acid derivatives for vision and memory disorders |
US7338976B1 (en) * | 1998-08-14 | 2008-03-04 | Gpi Nil Holdings, Inc. | Heterocyclic esters or amides for vision and memory disorders |
US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
EP1227859B1 (en) * | 1999-11-12 | 2006-08-09 | Alcon, Inc | Neurophilin ligands for treating ocular conditions |
GB0012383D0 (en) * | 2000-05-22 | 2000-07-12 | Novartis Ag | Organic compounds |
WO2003061519A2 (en) * | 2002-01-18 | 2003-07-31 | Massachusetts Eye And Ear Infirmary | Methods and compositions for preserving the viability of photoreceptor cells |
US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
US7083802B2 (en) | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
US7083803B2 (en) | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
US7087237B2 (en) | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
TW200517114A (en) | 2003-10-15 | 2005-06-01 | Combinatorx Inc | Methods and reagents for the treatment of immunoinflammatory disorders |
WO2007011880A2 (en) | 2005-07-18 | 2007-01-25 | Minu, L.L.C. | Enhanced ocular neuroprotection/neurostimulation |
US7592330B2 (en) * | 2005-08-08 | 2009-09-22 | Massachusetts Eye And Ear Infirmary | Methods and compositions for preserving the viability of photoreceptor cells |
JP2009514969A (en) | 2005-11-09 | 2009-04-09 | コンビナトアールエックス インコーポレーティッド | Methods, compositions, and kits for treating medical conditions |
WO2008042216A2 (en) | 2006-09-28 | 2008-04-10 | Follica, Inc. | Methods, kits, and compositions for generating new hair follicles and growing hair |
KR20090094090A (en) * | 2006-12-28 | 2009-09-03 | 리머릭 바이오파르마 인코오포레이티드 | Methods and compositions for therapeutic treatment |
WO2008127746A1 (en) | 2007-01-10 | 2008-10-23 | Board Of Regents The University Of Texas System | Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery |
MX2010001141A (en) * | 2007-07-31 | 2010-03-01 | Limerick Biopharma Inc | Phosphorylated pyrone analogs and methods. |
WO2010021681A2 (en) * | 2008-08-18 | 2010-02-25 | Combinatorx (Singapore) Pte. Ltd. | Compositions and methods for treatment of viral diseases |
US20110130711A1 (en) * | 2009-11-19 | 2011-06-02 | Follica, Inc. | Hair growth treatment |
WO2012118863A1 (en) * | 2011-02-28 | 2012-09-07 | The Schepens Eye Research Institute, Inc. | Therapies that target autoimmunity for treating glaucoma and optic neuropathy |
US10428331B2 (en) | 2014-01-16 | 2019-10-01 | Musc Foundation For Research Development | Targeted nanocarriers for the administration of immunosuppressive agents |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
CA2054983A1 (en) * | 1990-11-08 | 1992-05-09 | Sotoo Asakura | Suspendible composition and process for preparing the same |
EP0581959B1 (en) * | 1991-04-26 | 2001-01-17 | Fujisawa Pharmaceutical Co., Ltd. | Use of macrolide compounds for eye diseases |
ZA924953B (en) * | 1991-07-25 | 1993-04-28 | Univ Louisville Res Found | Method of treating ocular inflammation |
US5922773A (en) * | 1992-12-04 | 1999-07-13 | The Children's Medical Center Corp. | Glaucoma treatment |
WO1997031020A1 (en) * | 1996-02-22 | 1997-08-28 | The General Hospital Corporation | METHODS AND COMPOSITIONS FOR ENHANCING CELLULAR RESPONSE TO TGF-β LIGANDS |
US5994388A (en) * | 1997-03-18 | 1999-11-30 | The Children's Medical Center Corporation | Cytochalasin and isoindolinone derivatives as inhibitors of angiogenesis |
-
1999
- 1999-02-17 DE DE69907418T patent/DE69907418T2/en not_active Expired - Fee Related
- 1999-02-17 PT PT99905206T patent/PT1056454E/en unknown
- 1999-02-17 DK DK99905206T patent/DK1056454T3/en active
- 1999-02-17 AT AT99905206T patent/ATE238792T1/en not_active IP Right Cessation
- 1999-02-17 JP JP2000532120A patent/JP2002503692A/en active Pending
- 1999-02-17 ES ES99905206T patent/ES2192832T3/en not_active Expired - Lifetime
- 1999-02-17 US US09/622,035 patent/US6384073B1/en not_active Expired - Fee Related
- 1999-02-17 EP EP99905206A patent/EP1056454B1/en not_active Expired - Lifetime
- 1999-02-17 WO PCT/JP1999/000681 patent/WO1999042104A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
DE69907418D1 (en) | 2003-06-05 |
US6384073B1 (en) | 2002-05-07 |
WO1999042104A1 (en) | 1999-08-26 |
EP1056454B1 (en) | 2003-05-02 |
JP2002503692A (en) | 2002-02-05 |
DK1056454T3 (en) | 2003-08-18 |
EP1056454A1 (en) | 2000-12-06 |
PT1056454E (en) | 2003-08-29 |
ATE238792T1 (en) | 2003-05-15 |
DE69907418T2 (en) | 2003-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2192832T3 (en) | USE OF MACROLID COMPOUNDS TO TREAT GLAUCOMA. | |
ID21526A (en) | 4-HYDROXYQUINOLIN-3-CARBOXOXIDE AND HYDRAZIDE AS ANTI-VIRUS INGREDIENTS | |
BR9911482A (en) | Compound, pharmaceutical composition, use of the compound, and, processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound | |
PT842934E (en) | 5-HT1F AGONISTS | |
DK0915898T3 (en) | Crystal form I of clarithromycin | |
BRPI0207961A8 (en) | USE OF EPOTHYLONE AND CAPECITABIN ANALOGS TO MANUFACTURE DRUG TO TREAT SOLID CANCEROUS TUMORS AND KIT COMPRISING THE SAID COMPOUNDS. | |
ID29393A (en) | COMPOSITION OF CANCER TREATMENT AND METHOD OF USING NATURAL PLANT ESENSIL OILS | |
ATE468889T1 (en) | COSMETIC COMPOSITION FOR THE TREATMENT OF AGING AND/OR STRESSED SKIN | |
DE59409312D1 (en) | IMIDAZOPYRIDINE AND THEIR APPLICATION FOR THE TREATMENT OF STOMELINE DISEASES | |
ES2080297T3 (en) | DERIVATIVES 17-G (B)-SUBSTITUTED-4-AZA-5G (A) -ANDROSTAN-3-ONA AND PROCEDURE FOR THE PREPARATION OF THESE. | |
BR0318278A (en) | aminocyclohexyl ether compounds and uses thereof | |
BR0015392A (en) | Lipoxin a4 and its analogs for the treatment of dry eye | |
BR0109211A (en) | 5-ht1a Activity Compounds Useful for Treatment of External Retinal Disorders | |
BR0011225A (en) | Agent to treat dry eyes, its method and use | |
BR9914128A (en) | Antibiotic compositions for treatment of the eye, ear and nose | |
PT932613E (en) | EXPRESSION OF BLOCKING VIRULENCE FACTS IN S. AUREUS | |
BRPI0017528B8 (en) | use of a composition containing ketotifen salt | |
AU2001289714A1 (en) | Benzofuran derivatives and their use as antibacterial agents | |
BR9908796A (en) | Use of macrolide compounds, method of treatment and prevention of ards, pharmaceutical composition and macrolide compound | |
BR0009194A (en) | Composition of resorcinol | |
RU94045256A (en) | Use of benzo[g]quinolines | |
IL111804A0 (en) | Pharmaceutical compositions comprising dimeticone for the treatment of constipation | |
ES2082212T3 (en) | NEW ALPHA-GLUCOSIDASE INHIBITORS. | |
ES2190581T3 (en) | 2-OPTICALLY ACTIVE AMINOTETRALINE, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT, ACTIVE IN THE PREVENTION AND TREATMENT OF SEPTIC SHOCK. | |
BR9507732A (en) | Pharmaceutical composition for the treatment of glaucoma |